Oncolytic virus and anti-4-1BB combination therapy elicits strong antitumor immunity against established cancer
Version 2 2024-06-04, 14:51Version 2 2024-06-04, 14:51
Version 1 2023-10-24, 05:05Version 1 2023-10-24, 05:05
journal contribution
posted on 2024-06-04, 14:51 authored by Liza RaymondLiza Raymond, LJ Howland, JK Flynn, AC West, C Devaud, CP Duong, TJ Stewart, JA Westwood, ZS Guo, DL Bartlett, MJ Smyth, MH Kershaw, PK DarcyOncolytic virus and anti-4-1BB combination therapy elicits strong antitumor immunity against established cancer
History
Journal
Cancer ResearchVolume
72Pagination
1651-1660Location
Philadelphia, Pa.Publisher DOI
ISSN
0008-5472eISSN
1538-7445Language
engPublication classification
C1.1 Refereed article in a scholarly journalIssue
7Publisher
American Association for Cancer ResearchUsage metrics
Categories
No categories selectedLicence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC